Integrins are transmembrane receptors that link the cytoskeleton to the extracellular matrix (ECM), [1a] mediating cell-cell and cell-matrix adhesion and providing the traction for cell mobility and invasion.[1b] They are involved in tumour cell proliferation, migration and survival. Integrin a v b 3 and a v b 5 expression is correlated with disease progression in various tumor types (melanoma, [2a] prostate, [2b] glioblastoma [2c] ). They bind to the Arg-Gly-Asp (RGD) motif as their primary recognition sequence.[3] In recent years, both preclinical and clinical studies have demonstrated the effectiveness of various integrin antagonists in blocking tumor progression. The cyclic peptide c(ArgGly-Asp-d-Phe-NMe-Val) (cilengitide), developed by Kessler and co-workers, [4] is an a v b 3 and a v b 5 antagonist that displayed activity in patients with glioblastoma during phase III clinical trials. The most detailed information so far available for understanding of the structural basis of the interaction is provided by the X-ray structure of cilengitide bound to the a v b 3 headpiece: the arginine of the RGD motif associates with the a v subunit and the aspartate coordinates the bivalent metal ion on the b 3 subunit.[5] Because the RGD motif occurs in many extracellular matrix ligands, the recognition specificity would be expected to be modified by other residues and to depend on the conformation of the RGD sequence. Detailed comparison with different ligands for the same integrin binding site might shed light on the essential elements that determine their interactions, specificities and affinities, and might also allow the rational design of new antagonists. The properties of integrins embedded into cell membranes can differ from those of purified receptors, so we have carried out a NMR study (by saturation transfer difference and trNOESY techniques) of the interactions between ECV304[6a] cells (bladder cancer cells in which integrin a v b 3 is highly expressed [6b] ) and the two cyclic RGD mimics 1 and 2 (Scheme 1), with different configurational and structural features. [7] We show that the interactions between these small ligands and membrane-bound proteins can be observed by NMR directly in H 2 O buffer suspensions of living cells. The data allowed us to identify (by STD) the portions of the ligands in closest contact with the protein and to define (by trNOESY) the preferred conformations of the bound ligands. These NMR techniques [8] focus on the NMR signals of the ligands, exploiting NOE effects between protein and ligands in the proteinligand complexes.The ligands, the cyclic RGD pentapeptide mimics 1 and 2 (Scheme 1), previously described by workers from our laboratory, [7] are each characterized by a benzylic group connected to carbon 3 of the lactam unit, but differ in the configurations of the C-3 and C-7 lactam stereocentres. As already reported, [7] the conformational preferences of these compounds in the free state are modulated by the configurations of the bicyclic lactam, and so are their affini...